GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
11 May 2026 03:30 PM
RNS
Director/PDMR Shareholding
11 May 2026 07:05 AM
RNS
Collaboration with CTTQ for bepirovirsen
11 May 2026 07:00 AM
RNS
GSK - final tranche of share buyback programme
06 May 2026 06:22 PM
RNS
Result of AGM
05 May 2026 03:30 PM
RNS
Director/PDMR Shareholding
01 May 2026 03:00 PM
RNS
Holding(s) in Company
01 May 2026 03:00 PM
RNS
Total Voting Rights
29 Apr 2026 03:30 PM
RNS
Director/PDMR Shareholding
29 Apr 2026 07:00 AM
RNS
1st Quarter Results
28 Apr 2026 03:30 PM
RNS
Director/PDMR Shareholding
28 Apr 2026 07:00 AM
RNS
Bepirovirsen priority review US filing acceptance
27 Apr 2026 12:00 PM
RNS
Efimosfermin granted US/EU regulatory designations
27 Apr 2026 07:00 AM
RNS
TESARO update on AnaptysBio Inc. litigation
24 Apr 2026 03:30 PM
RNS
Director/PDMR Shareholding
23 Apr 2026 07:00 AM
RNS
Transaction in Own Shares
22 Apr 2026 07:00 AM
RNS
Transaction in Own Shares
21 Apr 2026 07:00 AM
RNS
Transaction in Own Shares
20 Apr 2026 03:30 PM
RNS
Director/PDMR Shareholding
20 Apr 2026 07:00 AM
RNS
Blenrep approved in China for 2L+ multiple myeloma
20 Apr 2026 07:00 AM
RNS
Transaction in Own Shares
17 Apr 2026 07:00 AM
RNS
Transaction in Own Shares
16 Apr 2026 03:30 PM
RNS
Director/PDMR Shareholding
16 Apr 2026 07:00 AM
RNS
Transaction in Own Shares
15 Apr 2026 07:12 AM
RNS
GSK completes acquisition of 35Pharma Inc.
15 Apr 2026 07:00 AM
RNS
Transaction in Own Shares
14 Apr 2026 03:30 PM
RNS
Director/PDMR Shareholding
14 Apr 2026 07:00 AM
RNS
Transaction in Own Shares
13 Apr 2026 03:30 PM
RNS
Director/PDMR Shareholding
13 Apr 2026 07:00 AM
RNS
Transaction in Own Shares
13 Apr 2026 07:00 AM
RNS
GSK presents positive data for BEHOLD 1 B7 H4 ADC
10 Apr 2026 03:30 PM
RNS
Director/PDMR Shareholding
10 Apr 2026 07:00 AM
RNS
Transaction in Own Shares
09 Apr 2026 03:30 PM
RNS
Director/PDMR Shareholding
09 Apr 2026 07:00 AM
RNS
Transaction in Own Shares
08 Apr 2026 07:00 AM
RNS
Exdensur approved for CRSwNP in China
08 Apr 2026 07:00 AM
RNS
Transaction in Own Shares
07 Apr 2026 07:00 AM
RNS
Transaction in Own Shares
02 Apr 2026 07:00 AM
RNS
Transaction in Own Shares
01 Apr 2026 03:30 PM
RNS
Director/PDMR Shareholding
01 Apr 2026 03:00 PM
RNS
Total Voting Rights
01 Apr 2026 07:00 AM
RNS
ViiV completes changes to minority shareholding
01 Apr 2026 07:00 AM
RNS
Transaction in Own Shares
31 Mar 2026 07:00 AM
RNS
Transaction in Own Shares
30 Mar 2026 07:05 AM
RNS
Bepirovirsen accepted for review in China
30 Mar 2026 07:00 AM
RNS
Exdensur approved for severe asthma in China
30 Mar 2026 07:00 AM
RNS
Transaction in Own Shares
27 Mar 2026 07:00 AM
RNS
Bepirovirsen accepted for review by the EMA
27 Mar 2026 07:00 AM
RNS
Transaction in Own Shares
26 Mar 2026 07:00 AM
RNS
Transaction in Own Shares
25 Mar 2026 03:30 PM
RNS
Director/PDMR Shareholding

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100

Latest directors dealings